IL91706A - Pharmaceutical compositions comprising in separate dosage form a plasminogen activator and hirudin - Google Patents
Pharmaceutical compositions comprising in separate dosage form a plasminogen activator and hirudinInfo
- Publication number
- IL91706A IL91706A IL91706A IL9170689A IL91706A IL 91706 A IL91706 A IL 91706A IL 91706 A IL91706 A IL 91706A IL 9170689 A IL9170689 A IL 9170689A IL 91706 A IL91706 A IL 91706A
- Authority
- IL
- Israel
- Prior art keywords
- hirudin
- dosage form
- plasminogen activator
- separate dosage
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888822147A GB8822147D0 (en) | 1988-09-21 | 1988-09-21 | Pharmaceutically active combination |
Publications (2)
Publication Number | Publication Date |
---|---|
IL91706A0 IL91706A0 (en) | 1990-06-10 |
IL91706A true IL91706A (en) | 1997-07-13 |
Family
ID=10643975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL91706A IL91706A (en) | 1988-09-21 | 1989-09-20 | Pharmaceutical compositions comprising in separate dosage form a plasminogen activator and hirudin |
Country Status (15)
Country | Link |
---|---|
US (1) | US5126134A (de) |
EP (1) | EP0365468B1 (de) |
JP (1) | JPH02121934A (de) |
KR (1) | KR0149001B1 (de) |
AT (1) | ATE101524T1 (de) |
AU (1) | AU628854B2 (de) |
CA (1) | CA1336493C (de) |
DE (1) | DE68913132T2 (de) |
DK (1) | DK463989A (de) |
GB (1) | GB8822147D0 (de) |
IE (1) | IE62434B1 (de) |
IL (1) | IL91706A (de) |
NZ (1) | NZ230691A (de) |
PH (1) | PH27420A (de) |
ZA (1) | ZA897173B (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8927722D0 (en) * | 1989-12-07 | 1990-02-07 | British Bio Technology | Proteins and nucleic acids |
US5837808A (en) * | 1991-08-20 | 1998-11-17 | Baxter International Inc. | Analogs of hirudin |
WO1993014199A1 (en) * | 1992-01-13 | 1993-07-22 | Abbott Laboratories | A pump-1 catalyzed method of making low molecular weight urokinase-type plasminogen activator |
ZA936478B (en) * | 1992-09-03 | 1994-09-30 | Regeneron Pharma | Dorsal tissue affecting factor and compositions |
EP0625580A4 (en) * | 1992-09-28 | 1994-12-21 | Japan Energy Corporation | Novel hirudine variant, process for producing the same, and anticoagulant containing the same as active ingredient. |
DE4323754C1 (de) * | 1993-07-15 | 1994-12-01 | Gruenenthal Gmbh | Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung |
US5972648A (en) * | 1993-09-28 | 1999-10-26 | Japan Energy Corporation | Hirudin analogs, methods of manufacture thereof and anticoagulant compositions having these as active ingredients |
US5510330A (en) * | 1994-03-25 | 1996-04-23 | Boehringer Mannheim Gmbh | Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
US5759542A (en) * | 1994-08-05 | 1998-06-02 | New England Deaconess Hospital Corporation | Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases |
DE4440892A1 (de) * | 1994-11-17 | 1996-05-23 | Gruenenthal Gmbh | Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften |
US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
GB2394498B (en) * | 2002-10-23 | 2006-08-09 | Engineering Business Ltd | Mounting of offshore structures |
GB0306547D0 (en) * | 2003-03-21 | 2003-04-23 | Engineering Business Ltd | Apparatus for creating a local reduction in wave height |
US20050036984A1 (en) * | 2003-06-17 | 2005-02-17 | Harrison Roger G. | Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof |
US20110002978A1 (en) | 2003-06-17 | 2011-01-06 | Harrison Roger G | Enzyme prodrug cancer therapy selectively targeted to tumor cells or tumor vasculature and methods of production and use thereof |
US7976847B2 (en) * | 2004-01-13 | 2011-07-12 | Vasogenix Pharmaceuticals, Inc. | Controlled release CGRP delivery composition for cardiovascular and renal indications |
WO2005070445A2 (en) * | 2004-01-13 | 2005-08-04 | Vasogenix Pharmaceuticals, Inc. | Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same |
CA2552757A1 (en) * | 2004-01-13 | 2005-08-04 | Vasogenix Pharmaceuticals, Inc. | Methods of using cgrp for cardiovascular and renal indications |
ATE414010T1 (de) * | 2004-08-03 | 2008-11-15 | Ihc Engineering Business Ltd | Zugangsverfahren zwischen schiffskonstruktionen und gerät |
GB0503083D0 (en) * | 2005-02-15 | 2005-03-23 | Engineering Business Ltd | Launch and recovery apparatus and method |
UA95903C2 (ru) | 2005-02-24 | 2011-09-26 | Дифьюжен Фармасьютикалз Ллк | Транс-каротиноиды, их синтез, лекарственная форма и применение |
GB2428656B (en) | 2005-08-01 | 2009-08-05 | Engineering Business Ltd | Gangway apparatus |
GB2434823A (en) * | 2006-02-06 | 2007-08-08 | Engineering Business Ltd | Transport and installation of offshore structures |
JP2010524855A (ja) | 2007-04-13 | 2010-07-22 | ディフュージョン・ファーマシューティカルズ・エルエルシー | 末梢血管疾患の前処置としての、及びその処置における双極性トランスカロテノイドの使用 |
US20090214469A1 (en) * | 2008-02-25 | 2009-08-27 | Jeffrey Gold | Methods and Compositions for the Treatment of Sepsis |
CN108464976A (zh) | 2009-06-22 | 2018-08-31 | 扩散药品有限公司 | 扩散促进化合物及其单独或与溶栓药一起的应用 |
EP2575487B1 (de) | 2010-06-02 | 2017-10-18 | Diffusion Pharmaceuticals Llc | Orale formulierungen aus bipolaren transkarotinoiden |
US9987241B2 (en) | 2014-09-25 | 2018-06-05 | The Board Of Regents Of The University Of Oklahoma | Enzyme conjugate and prodrug cancer therapy |
CN115089569A (zh) | 2016-03-24 | 2022-09-23 | 扩散药品有限公司 | 双极性反式类胡萝卜素连同化疗和放射治疗在治疗癌症中的用途 |
US11446365B2 (en) | 2017-08-09 | 2022-09-20 | The Board Of Regents Of The University Of Oklahoma | Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same |
US11613744B2 (en) | 2018-12-28 | 2023-03-28 | Vertex Pharmaceuticals Incorporated | Modified urokinase-type plasminogen activator polypeptides and methods of use |
MX2021007843A (es) | 2018-12-28 | 2021-08-11 | Vertex Pharma | Polipeptidos de activador de plasminogeno, tipo urocinasa, modificados y metodos de uso. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8003402A (nl) * | 1980-06-11 | 1982-01-04 | Leuven Res & Dev Vzw | Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking. |
DE3342139A1 (de) * | 1983-11-22 | 1985-05-30 | Ciba-Geigy Ag, Basel | Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel |
JPS61112018A (ja) * | 1984-11-06 | 1986-05-30 | Mitsubishi Chem Ind Ltd | 線溶増強剤 |
DE3544318A1 (de) * | 1985-12-14 | 1987-06-19 | Behringwerke Ag | Mittel aus einem plasmin-inhibitor und einem plasminogen-aktivator zur behandlung von thrombosen |
JP2739050B2 (ja) * | 1988-01-28 | 1998-04-08 | ヘキスト薬品工業株式会社 | 抗血液凝固剤 |
DE3804600A1 (de) * | 1988-02-13 | 1989-08-24 | Basf Ag | Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz |
-
1988
- 1988-09-21 GB GB888822147A patent/GB8822147D0/en active Pending
-
1989
- 1989-09-12 EP EP89810676A patent/EP0365468B1/de not_active Revoked
- 1989-09-12 AT AT89810676T patent/ATE101524T1/de not_active IP Right Cessation
- 1989-09-12 DE DE68913132T patent/DE68913132T2/de not_active Revoked
- 1989-09-13 AU AU41352/89A patent/AU628854B2/en not_active Ceased
- 1989-09-18 US US07/408,836 patent/US5126134A/en not_active Expired - Fee Related
- 1989-09-19 PH PH39253A patent/PH27420A/en unknown
- 1989-09-19 NZ NZ230691A patent/NZ230691A/en unknown
- 1989-09-19 CA CA000611903A patent/CA1336493C/en not_active Expired - Fee Related
- 1989-09-20 IE IE301589A patent/IE62434B1/en not_active IP Right Cessation
- 1989-09-20 IL IL91706A patent/IL91706A/xx not_active IP Right Cessation
- 1989-09-20 KR KR1019890013492A patent/KR0149001B1/ko not_active IP Right Cessation
- 1989-09-20 DK DK463989A patent/DK463989A/da not_active Application Discontinuation
- 1989-09-20 ZA ZA897173A patent/ZA897173B/xx unknown
- 1989-09-20 JP JP1242356A patent/JPH02121934A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US5126134A (en) | 1992-06-30 |
ZA897173B (en) | 1990-09-26 |
AU628854B2 (en) | 1992-09-24 |
IL91706A0 (en) | 1990-06-10 |
CA1336493C (en) | 1995-08-01 |
EP0365468A1 (de) | 1990-04-25 |
EP0365468B1 (de) | 1994-02-16 |
IE893015L (en) | 1990-03-21 |
IE62434B1 (en) | 1995-02-08 |
ATE101524T1 (de) | 1994-03-15 |
DK463989D0 (da) | 1989-09-20 |
AU4135289A (en) | 1990-03-29 |
DE68913132T2 (de) | 1994-07-07 |
DE68913132D1 (de) | 1994-03-24 |
DK463989A (da) | 1990-03-22 |
PH27420A (en) | 1993-06-21 |
KR900004349A (ko) | 1990-04-12 |
GB8822147D0 (en) | 1988-10-26 |
KR0149001B1 (ko) | 1998-10-15 |
JPH02121934A (ja) | 1990-05-09 |
NZ230691A (en) | 1992-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL91706A (en) | Pharmaceutical compositions comprising in separate dosage form a plasminogen activator and hirudin | |
ZA921875B (en) | New esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions | |
ES2011120A6 (es) | Forma de dosificacion para tratar las enfermedades cardiovasculares. | |
WO1994027589A3 (en) | Antidepressant dosage form | |
NZ230036A (en) | Intravenous pharmaceutical composition comprising cyclosporin | |
IL96691A0 (en) | Hiv protease inhibitors and pharmaceutical compositions containing them | |
NZ223598A (en) | Zinc-protamine-alpha interferon complexes and pharmaceutical compositions | |
ZA928771B (en) | Combination chemotherapy | |
NZ228754A (en) | Vitamin d analogues and pharmaceutical compositions | |
IL92007A0 (en) | Pharmaceutical compositions containing gestodene | |
IL76932A (en) | Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen | |
AU587307B2 (en) | Verapamil dosage form | |
ZA89792B (en) | Pharmaceutical compositions with improved stability | |
NZ233122A (en) | Synergistic pharmaceutical composition comprising ketanserine and an ace inhibitor | |
IL92672A0 (en) | Retroviral protease inhibitors,their preparation and pharmaceutical compositions containing them | |
IL89502A0 (en) | Plantinum derivatives and pharmaceutical compositions containing the same | |
MD970269A (en) | Clavulanates | |
IL90065A0 (en) | 1alpha-hydroxyvitamin-d homologs and pharmaceutical compositions containing them | |
DE3380166D1 (en) | Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor, useful for the treatment of the myocardium infarction | |
NZ229816A (en) | Imidazolylalkyl-substituted annelated indoloketone derivatives and pharmaceutical compositions | |
IL92107A0 (en) | Quinazoline derivatives,and pharmaceutical compositions containing them | |
IL90958A0 (en) | Cycloalkylthiazole derivatives,their manufacture and pharmaceutical compositions containing them | |
ES8704903A1 (es) | Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido. | |
EP0468327A3 (en) | Oral pharmaceutical compositions containing hirudin | |
HUT63575A (en) | Stabilized pharmaceutical composition comprising the reduced form of non-glycosylated, recombinant human interleukin-2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
RH | Patent void | ||
RH1 | Patent not in force |